Tg Therapeutics Inc (TGTX)

Deferred Revenue

$16.83M

Quarterly · Period ending: · USD

TGTX logo

TGTX Deferred Revenue

Latest reported$21.23M
TGTX FY Deferred Revenue ($0.00 → $21.23M)
High-resolution chart · PNG

TGTX deferred revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
21,234,000
11,414,000
152,000
0
0
0
0
152,000
152,381
152,381
152,381
152,381
152,381
152,381
0
480,890
257,968
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.